SCHEMBL23799304

SCHEMBL23799304

CCCc1cccnc1NC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.55
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
KDM4E B2RXH2 3/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
GAA P10253 1/20 0.38
ADRA2B P18089 3/20 0.37
ADRA2C P18825 3/20 0.37
ADRA2A P08913 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
CASP3 P42574 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13073819 0.89 GRM5 (0.45) GRM5ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL17827959 0.86 GRM5 (0.41) GRM5ALDH1A1HPGDKDM4EHSD17B10
Hydrochloric Acid SCHEMBL11525180 0.84 GRM5 (0.41) GRM5ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL6634184 0.82 GRM5 (0.40) GRM5ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL21281619 0.82 GRM5 (0.40) GRM5ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL23798616 0.82 GRM5 (0.54) GRM5ALDH1A1HPGDKDM4EHSD17B10
Bromide SCHEMBL6633796 0.81 GRM5 (0.39) GRM5ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL31510053 0.80 TRPV1 (0.41) GRM5ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL317954 0.80 AOC1 (0.43) GRM5ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL20457772 0.80 GRM5 (0.37) GRM5ALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3526207-B1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LTD (GB) 2021-09-08 EP disclosed